The Gugging Swallowing Screen (GUSS) was developed 2006 at the university clinic Gugging in cooperation with the Department of Clinical Neurosciences and Preventive Medicine. It determines the severity of dysphagia and the risk of aspiration in acute-stroke patients. Meanwhile it has been translated in more than 16 languages and is used around the world.
The GUSS was created out of a need for a new screening procedure for the assessment of aspiration risk and dysphagia in clinical practice. Previous swallowing screens had been restricted to water testing procedures, which determine only the risk of aspiration for water but do not give any information on dietary recommendations. We therefore developed a stepwise assessment tool to enable a graded rating with separate evaluations for non-fluid and fluid nutrition using the grading of the IDDSI framework (www.idddsi.org).
Compared to other dysphagia screens, the test sequence of the GUSS is unique: it starts with saliva swallowing followed by swallowing of semi-solid food and finally fluid and solid textures. This sequence has been based in studies showing that acute-stroke patients have more problems swallowing thin liquids (such as water) than semisolid textures
The GUSS might enable a considerable proportion of acute stroke patients to continue eating semi-solid food while fluids are administered as indicated via intravenous line or nasogastric tube. A renunciation of oral food uptake altogether should be prevented, if possible.
The GUSS consists of 4 subtests and is divided into 2 parts: the preliminary assessment or indirect swallowing test (Subtest 1) and the direct swallowing test, which consists of 3 subtests. These 4 subtests must be performed sequentially.
In the indirect swallowing test: 1. vigilance; 2. voluntary cough and/or throat clearing; 3. saliva swallowing (swallowing, drooling, voice change) are assessed.
The direct swallowing test assesses the deglutition, involuntary cough, drooling and voice change within the semi-solid swallowing, liquid swallowing and solid swallowing trial.
Levels of severity
A maximum of 5 points can be reached in each subtest. This maximum must be attained to continue to the next subtest. Thus twenty points are the highest score that a patient can attain, and it denotes normal swallowing ability without aspiration risk.
In total 4 levels of severity can be determined:
0-9 Points: severe dysphagia and high aspiration risk.
10-14 Points: moderate dysphagia and moderate risk of aspiration
15-19 Points: mild dysphagia with mild aspiration
20 Points: normal swallowing ability
For each level of severity different diet recommendations are given.
Schwaninger A. Vergleich der Kosteinstufung aufgrund einer klinischen (Gugging Swallowing Screen) und einer instrumentellen (Fiberendoskopie) Schluckuntersuchung nach schwerem akutem Schlaganfall. Masterthese 2019. Donauuniversität Krems.
Schwaninger A, Teuschl Y, Trapl-Grundschober M. The Gugging Swallowing Screen (GUSS) recommends a similar diet as the Fiberoptic Endoscopic Evaluation of Swallowing (FEES) for severe strokes when coughing is evaluated critically. Poster 5. European Stroke Organisation Conference 2019, Milano, Italy.
Teuschl Y, Trapl M, Ratajczak P, Matz K, Dachenhausen A, Brainin M. Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. PLoS One. 2018;13:e0192142.
Teuschl Y, Trapl-Grundschober M, Ratajczak P, Matz K, Dachenhausen A, Brainin M. Patients with mild as well as with severe acute strokes benefit from systematic dysphagia screening and dietary modification to prevent pneumonia -a registry study. Poster und Postervortrag 11. World Stroke Congress 2018, Montreal, Canada.
Christensen M, Trapl M. Development of a modified swallowing screening tool to manage post-extubation dysphagia. Nurs Crit Care. 2018;23:102-107.
Trapl M, Teuschl Y, Matz K, Dachenhausen A, Brainin M. Overestimating the risk of aspiration in acute stroke. Eur J Neurol. 2017;24:e34.
Trapl M, Teuschl Y, Ratajczak P, Matz K, Dachenhausen A, Brainin M. The impact of dietary recommendations on stroke associated pneumonia based on the Gugging Swallowing Screen. Poster European Society for Swallowing Disorders (ESSD) und World Dysphagia Summit 2017, Barcelona, Spain.
Trapl M, Firlinger B, Teuschl Y, Dachenhausen A, Brainin M. International dissemination and usage of the Gugging Swallowing Screen (GUSS). A prospective cross sectional study. Poster ESSD Congress 2016, Milano, Italy.
Teuschl Y, Trapl M, Ratajczak P, Matz K, Brainin M. Real-world use of the Gugging Swallowing Screen on a stroke-unit. 3. European Stroke Organisation Conference 2017, Prag, Czech Republic.
Trapl M. Anwendung des Gugging Swallowing Screen im klinischen Alltag auf einer Stroke Unit. Neurologisch. neuro 2017; 03.
Prof. emer. Dr. Michael Brainin
- Department Clinical Neurosciences and Preventive Medicine
Michaela PhDr. Trapl-Grundschober, MAS, MSc
Speech Language Therapist
- University Clinic Tulln